Published in Hospital Business Week, April 29th, 2007
This trend article about Nanjing Medical University, People's Republic of China, is an immediate alert from NewsRx to identify developing directions of research.
Study 1: Investigators publish new data in the report "Thrombolytic efficacy of native recombinant staphylokinase on femoral artery thrombus of rabbits." In this recent report, researchers in Nanjing, People's Republic of China conducted a study "To investigate the thrombolytic efficacy, ideal dosage and administration of native recombinant staphylokinase (r-SAK). Forty New Zealand rabbits were randomly...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week